For each citation that was shared on social media (LinkedIn, Facebook, or Twitter) with the “@GenScript” tag, the author will be rewarded with a $10 Amazon gift card or 2,000 GS points.

Modifiers of C9orf72 DPR toxicity implicate nucleocytoplasmic transport impairments in c9FTD/ALS

Nat Neurosci. 2015; 
Ana Jovičić,  Jerome Mertens,  Steven Boeynaems,  Elke Bogaert,  Noori Chai, Shizuka B. Yamada,  Joseph W. Paul, III,  Shuying Sun,  Joseph R. Herdy,  Gregor Bieri, Nicholas J. Kramer,  Fred H. Gage,  Ludo Van Den Bosch,  Wim Robberecht, ,  andAaron D. Gitler,
Products/Services Used Details Operation
Gene Synthesis … minimize the formation of stable RNA secondary structures. ATG-DPR-FLAG constructs were synthesized by Genscript (Piscataway, USA) and were flanked by attB sites. Constructs were further subcloned into a pDONR221 … Get A Quote

Abstract

C9orf72 mutations are the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Dipeptide repeat proteins (DPRs) produced by unconventional translation of the C9orf72 repeat expansions cause neurodegeneration in cell culture and in animal models. We performed two unbiased screens in Saccharomyces cerevisiae and identified potent modifiers of DPR toxicity, uncovering karyopherins and effectors of Ran-mediated nucleocytoplasmic transport, providing insight into potential disease mechanisms and therapeutic targets.

Keywords